Literature DB >> 32061319

Authoritarianism, outbreaks, and information politics.

Matthew M Kavanagh1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32061319      PMCID: PMC7129941          DOI: 10.1016/S2468-2667(20)30030-X

Source DB:  PubMed          Journal:  Lancet Public Health


× No keyword cloud information.
Are autocratic states such as China better equipped than their more democratic counterparts to respond to disease outbreaks? On Dec 31, 2019, China alerted WHO to an outbreak of pneumonia of unknown cause in the city of Wuhan in Hubei province. The epidemic quickly spread, with cases of a novel coronavirus (2019-nCoV) confirmed throughout China and elsewhere in Asia, Europe, North America, and Australia. The Chinese Government's forceful response has drawn praise from global health officials. Scholars and health leaders have long debated whether democracy improves, hinders, or is immaterial for public health.1, 2, 3 Does this signal an authoritarian advantage in tackling outbreaks? On the surface, the power of authoritarianism is on display in China's response to 2019-nCoV. The Huanan seafood market suspected as the outbreak source was closed and decontaminated within a day of the announcement. Within 3 days of confirmed human-to-human transmission, with cases rising and the world's largest mass travel event underway for the lunar new year Spring Festival, the Chinese Government imposed an unprecedented cordon sanitaire. Movement of more than 50 million people across Hubei province was rapidly restricted, curtailing transportation inside cities and outbound transportation by air, train, and bus. Authorities halted Spring Festival celebrations in Beijing and restricted movement into other major cities. Two 1000-bed hospitals were built within days. These moves reflect a level of control only available to authoritarian governments. WHO officials have congratulated China for setting “a new standard for outbreak response”. Yet, time is key to controlling outbreaks; getting good information and acting on it rapidly can halt outbreaks before they need emergency measures. The early history of the 2019-nCoV outbreak raises questions about whether this situation is an example of beneficial autocracy. For Amartya Sen, authoritarian states face serious challenges in information and accountability. Governments in closed political systems, without open media and opposition parties, struggle to receive accurate information in a timely manner and to convey urgent information to the public. Governments can be the victims of their own propaganda, because the country's political institutions provide incentives to local officials to avoid sharing bad news with their central bosses and await instructions before acting. Information politics in China undermined a rapid response to the 2019-nCoV outbreak. Health-care workers suspected an outbreak in early December, 2019, but information with which the public might have taken preventive measures was suppressed, and communication channels that might have alerted senior officials to the growing threat were shut down. Police detained a clinician and seven other people posting reports on 2019-nCoV, threatening punishment for spreading so-called rumors. Social media was censored; a preliminary analysis of Weibo and WeChat published on China's biggest online platform showed outbreak discussions were nearly non-existent through much of January, 2020, until the Chinese Government changed its official stance on Jan 20, 2020. Through much of January, 2020, the Wuhan Municipal Health Commission reported no evidence of human-to-human transmission, no infection among health workers, that severe cases of disease caused by 2019-nCoV infection were confined to those with underlying conditions and older people, and that the Huanan seafood market was the source. Reports in The Lancet and New England Journal of Medicine, however, show that half of patients admitted to intensive-care units were aged 25–49 years, and two-thirds had no underlying illnesses. Human-to-human transmission and health-worker infection were evident before the Chinese Government made an announcement. This information either did not make it to authorities or the public were misinformed. The Mayor of Wuhan has said publicly that not only was information not revealed in a timely manner but also they did not use information effectively. By the time quarantine went into effect on Jan 23, 2020, five million people had left the city of Wuhan for holiday travel. Outbreaks were subsequently reported throughout China. Without open media and an opposition to check on bureaucratic hierarchy, knowledge from the front lines of the 2019-nCoV outbreak did not reach Beijing. Weeks into the outbreak, leaders were forced to publicly threaten that officials withholding information “will be nailed on the pillar of shame for eternity”. Is there an authoritarian advantage in disease response? It seems that authoritarian information politics inhibited a rapid response to the 2019-nCoV outbreak in China, which could have limited the crisis. It is not yet clear if the extraordinary cordons and influx of resources enabled by autocratic rule will prove a successful public health strategy. Yet, in building capacity to prevent, detect, and respond to outbreaks, democratic openness and competitive politics seem more asset than inadequacy.
  4 in total

1.  Democracy and health.

Authors:  J P Ruger
Journal:  QJM       Date:  2005-04

2.  The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis.

Authors:  Thomas J Bollyky; Tara Templin; Matthew Cohen; Diana Schoder; Joseph L Dieleman; Simon Wigley
Journal:  Lancet       Date:  2019-03-14       Impact factor: 202.731

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

  4 in total
  13 in total

Review 1.  Coronavirus pandemic (COVID-19) and its natural environmental impacts.

Authors:  P F Rupani; M Nilashi; R A Abumalloh; S Asadi; S Samad; S Wang
Journal:  Int J Environ Sci Technol (Tehran)       Date:  2020-09-01       Impact factor: 2.860

2.  Evidence-Based Framework and Implementation of China's Strategy in Combating COVID-19.

Authors:  Dahai Zhao; Haijiang Lin; Zhiruo Zhang
Journal:  Risk Manag Healthc Policy       Date:  2020-10-07

3.  Governments and international institutions should urgently attend to the unjust disparities that COVID-19 is exposing and causing.

Authors:  Luis Alberto Martinez-Juarez; Ana Cristina Sedas; Miriam Orcutt; Raj Bhopal
Journal:  EClinicalMedicine       Date:  2020-06-04

4.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.

Authors:  Benjamin J Cowling; Sheikh Taslim Ali; Tiffany W Y Ng; Tim K Tsang; Julian C M Li; Min Whui Fong; Qiuyan Liao; Mike Yw Kwan; So Lun Lee; Susan S Chiu; Joseph T Wu; Peng Wu; Gabriel M Leung
Journal:  Lancet Public Health       Date:  2020-04-17

Review 5.  Behaviour adoption approaches during public health emergencies: implications for the COVID-19 pandemic and beyond.

Authors:  Mohamed F Jalloh; Aasli A Nur; Sophia A Nur; Maike Winters; Jamie Bedson; Danielle Pedi; Dimitri Prybylski; Apophia Namageyo-Funa; Kathy M Hageman; Brian J Baker; Mohammad B Jalloh; Eugenia Eng; Helena Nordenstedt; Avi J Hakim
Journal:  BMJ Glob Health       Date:  2021-01

6.  Information uncertainty: a correlate for acute stress disorder during the COVID-19 outbreak in China.

Authors:  Danhua Lin; Daniela B Friedman; Shan Qiao; Cheuk Chi Tam; Xiaoyan Li; Xiaoming Li
Journal:  BMC Public Health       Date:  2020-12-07       Impact factor: 3.295

7.  Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants.

Authors:  Shufang Sun; Danhua Lin; Don Operario
Journal:  medRxiv       Date:  2020-07-14

8.  Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Security, Infectious Disease Outbreaks, Epidemics, and Pandemics.

Authors:  Frederick M Burkle
Journal:  Prehosp Disaster Med       Date:  2020-04-08       Impact factor: 2.040

9.  Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.

Authors:  Eskild Petersen; David Hui; Davidson H Hamer; Lucille Blumberg; Lawrence C Madoff; Marjorie Pollack; Shui Shan Lee; Susan McLellan; Ziad Memish; Ira Praharaj; Sean Wasserman; Francine Ntoumi; Esam Ibraheem Azhar; Timothy D Mchugh; Richard Kock; Guiseppe Ippolito; Ali Zumla; Marion Koopmans
Journal:  Int J Infect Dis       Date:  2020-03-04       Impact factor: 3.623

10.  Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China).

Authors:  Hao Yu; Xu Sun; Wei Deng Solvang; Xu Zhao
Journal:  Int J Environ Res Public Health       Date:  2020-03-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.